サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1166111

血管性浮腫治療の世界市場 - 成長、将来展望、競合分析（2022年～2030年）

Angioedema Treatment Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 115 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
血管性浮腫治療の世界市場 - 成長、将来展望、競合分析（2022年～2030年）
出版日: 2022年08月11日
発行: Acute Market Reports
ページ情報: 英文 115 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医療投資の拡大、血管性浮腫の流行、高リスクの高齢者人口の増加が、血管性浮腫治療の世界市場の成長を促す主な要因となっています。今後数年間は、中国や日本などの経済圏で血管性浮腫治療の需要が大幅に増加すると予想されています。

当レポートでは、世界の血管性浮腫治療市場について調査し、市場動向、競合情報、セグメント分析、新興動向、技術分析、企業プロファイルなどの情報を提供しています。

目次

第1章 序文

  • レポートの説明
  • 市場セグメンテーション
  • 調査手法

第2章 エグゼクティブサマリー

  • 市場スナップショット：世界の血管性浮腫治療市場
  • 世界の血管性浮腫治療市場：治療別（2021年）
  • 世界の血管性浮腫治療市場：地域別（2021年）
  • COVID-19の影響
  • 魅力的な投資提案：地域別（2021年）
  • 競合分析
    • 主要な血管性浮腫治療市場ベンダーの市場ポジショニング
    • 血管性浮腫治療市場ベンダーが採用する戦略
    • 主要な業界戦略

第3章 血管性浮腫治療市場：ビジネスの見通しと市場力学

  • イントロダクション
  • 世界の血管性浮腫治療市場金額（2020年～2030年）
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進要因・抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォースモデル
  • PESTEL分析

第4章 血管性浮腫治療市場：治療別（2020年～2030年）

  • 市場概要
  • 成長と収益分析：2021年対2030年
  • 市場セグメンテーション
    • 抗ヒスタミン剤
    • コルチコステロイド
    • 自己免疫薬
    • 抗線溶薬
    • 血中タンパク質調節剤

第5章 北米の血管性浮腫治療市場（2020年～2030年）

  • 市場概要
  • 血管性浮腫治療市場：治療別（2020年～2030年）
  • 血管性浮腫治療市場：地域別（2020年～2030年）
    • 北米

第6章 英国・欧州連合の血管性浮腫治療市場（2020年～2030年）

  • 市場概要
  • 血管性浮腫治療市場：治療別（2020年～2030年）
  • 血管性浮腫治療市場：地域別（2020年～2030年）
    • 英国・欧州連合

第7章 アジア太平洋の血管性浮腫治療市場（2020年～2030年）

  • 市場概要
  • 血管性浮腫治療市場：治療別（2020年～2030年）
  • 血管性浮腫治療市場：地域別（2020年～2030年）
    • アジア太平洋

第8章 ラテンアメリカの血管性浮腫治療市場（2020年～2030年）

  • 市場概要
  • 血管性浮腫治療市場：治療別（2020年～2030年）
  • 血管性浮腫治療市場：地域別（2020年～2030年）
    • ラテンアメリカ

第9章 中東・アフリカの血管性浮腫治療市場（2020年～2030年）

  • 市場概要
  • 血管性浮腫治療市場：治療別（2020年～2030年）
  • 血管性浮腫治療市場：地域別（2020年～2030年）
    • 中東・アフリカ

第10章 企業プロファイル

  • AstraZeneca plc
  • F. Hoffmann-La Roche AG
  • Valeant Pharmaceuticals International.
  • Merck & Co.
  • Dyax Corp
  • CSL Behring
  • Pharming Group
  • ViroPharma
  • その他
図表

List of Tables

  • TABLE 1 Global Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 2 North America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 3 UK and European Union Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 4 Asia Pacific Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 5 Latin America Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)
  • TABLE 6 Middle East and Africa Angioedema Treatment Market By Treatment, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Angioedema Treatment Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Angioedema Treatment Market: Quality Assurance
  • FIG. 5 Global Angioedema Treatment Market, By Treatment, 2021
  • FIG. 6 Global Angioedema Treatment Market, By Geography, 2021
  • FIG. 7 Global Angioedema Treatment Market, By Treatment, 2021 Vs 2030, %
  • FIG. 8 U.S. Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 9 Canada Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 10 Rest of North America Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 11 UK Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 12 Germany Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 13 Spain Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 14 Italy Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 15 France Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 16 Rest of Europe Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 17 China Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 18 Japan Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 19 India Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 20 Australia Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 21 South Korea Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 22 Rest of Asia Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 23 Brazil Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 24 Mexico Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 25 Rest of Latin America Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 26 GCC Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 27 Africa Angioedema Treatment Market (US$ Million), 2020 - 2030
  • FIG. 28 Rest of Middle East and Africa Angioedema Treatment Market (US$ Million), 2020 - 2030
目次
Product Code: 137025-08-22

Growth in healthcare investments, prevalence of angioedema and growing high-risk geriatric population are the major factors driving the global market growth for angioedema treatment. In the next few years the demand for angioedema treatment is expected to increase significantly in the economies such as China and Japan. Rising incidence of hereditary angioedema and high awareness about treatment and the management of angioedema together drive the global hereditary angioedema market.

The treatments studies for analyzing the overall angioedema treatment market are Antihistamines, Corticosteroids, Autoimmune drugs, antifibrinolytic agents and blood protein controllers. Market size and forecast for each of these segments for the period 2020-2030 are provided in this study along with respective CAGRs for the forecast period 2022-2030. This report also highlights information about major clinical trial candidates under scrutiny for angioedema treatment. These candidates are categorized corresponding to their trial phase, namely phase I, phase II and phase III.

Market size and forecast for these regional and country level markets are presented in this study for the period 2020-2030. Market growth rates for the forecast period 2022-2030 are also included in this report, considering 2021 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global angioedema treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global angioedema treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in angioedema treatment market.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Angioedema Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Angioedema Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

Antihistamines

Cortecosteroids

Autoimmune Drugs

Antifibrinolytic Agents

Blood Protein Controllers

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Angioedema Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Angioedema Treatment market?

Which is the largest regional market for Angioedema Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Angioedema Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Angioedema Treatment market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Angioedema Treatment Market
  • 2.2. Global Angioedema Treatment Market, By Treatment, 2021 (US$ Million)
  • 2.3. Global Angioedema Treatment Market, By Geography, 2021 (US$ Million)
  • 2.4. Impact of Covid 19
  • 2.5. Attractive Investment Proposition by Geography, 2021
  • 2.6. Competitive Analysis
    • 2.6.1. Market Positioning of Key Angioedema Treatment Market Vendors
    • 2.6.2. Strategies Adopted by Angioedema Treatment Market Vendors
    • 2.6.3. Key Industry Strategies

3. Angioedema Treatment Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Angioedema Treatment Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Antihistamines
    • 4.3.2. Cortecosteroids
    • 4.3.3. Autoimmune Drugs
    • 4.3.4. Antifibrinolytic Agents
    • 4.3.5. Blood Protein Controllers

5. North America Angioedema Treatment Market, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 5.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
    • 5.3.1.North America
      • 5.3.1.1. U.S.
      • 5.3.1.2. Canada
      • 5.3.1.3. Rest of North America

6. UK and European Union Angioedema Treatment Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 6.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
    • 6.3.1.UK and European Union
      • 6.3.1.1. UK
      • 6.3.1.2. Germany
      • 6.3.1.3. Spain
      • 6.3.1.4. Italy
      • 6.3.1.5. France
      • 6.3.1.6. Rest of Europe

7. Asia Pacific Angioedema Treatment Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 7.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
    • 7.3.1.Asia Pacific
      • 7.3.1.1. China
      • 7.3.1.2. Japan
      • 7.3.1.3. India
      • 7.3.1.4. Australia
      • 7.3.1.5. South Korea
      • 7.3.1.6. Rest of Asia Pacific

8. Latin America Angioedema Treatment Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 8.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
    • 8.3.1.Latin America
      • 8.3.1.1. Brazil
      • 8.3.1.2. Mexico
      • 8.3.1.3. Rest of Latin America

9. Middle East and Africa Angioedema Treatment Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Angioedema Treatment Market: By Treatment, 2020-2030, USD (Million)
  • 9.3.Angioedema Treatment Market: By Region, 2020-2030, USD (Million)
    • 9.3.1.Middle East and Africa
      • 9.3.1.1. GCC
      • 9.3.1.2. Africa
      • 9.3.1.3. Rest of Middle East and Africa

10. Company Profile

  • 10.1. AstraZeneca plc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Portfolio
    • 10.1.4. Strategic Initiatives
  • 10.2. F. Hoffmann-La Roche AG
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Portfolio
    • 10.2.4. Strategic Initiatives
  • 10.3. Valeant Pharmaceuticals International.
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Portfolio
    • 10.3.4. Strategic Initiatives
  • 10.4. Merck & Co.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Portfolio
    • 10.4.4. Strategic Initiatives
  • 10.5. Dyax Corp
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Portfolio
    • 10.5.4. Strategic Initiatives
  • 10.6. CSL Behring
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Portfolio
    • 10.6.4. Strategic Initiatives
  • 10.7. Pharming Group
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Portfolio
    • 10.7.4. Strategic Initiatives
  • 10.8. ViroPharma
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Portfolio
    • 10.8.4. Strategic Initiatives
  • 10.9. Other Notable Players
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Portfolio
    • 10.9.4. Strategic Initiatives